These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27458237)

  • 1. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
    Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
    EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.
    Wagner SA; Satpathy S; Beli P; Choudhary C
    EMBO J; 2016 Sep; 35(17):1868-84. PubMed ID: 27307491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.
    Elliott PR; Leske D; Hrdinka M; Bagola K; Fiil BK; McLaughlin SH; Wagstaff J; Volkmar N; Christianson JC; Kessler BM; Freund SM; Komander D; Gyrd-Hansen M
    Mol Cell; 2016 Sep; 63(6):990-1005. PubMed ID: 27591049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.
    Kupka S; De Miguel D; Draber P; Martino L; Surinova S; Rittinger K; Walczak H
    Cell Rep; 2016 Aug; 16(9):2271-80. PubMed ID: 27545878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD.
    Griewahn L; Müller-Foxworth M; Peintner L; Wissler M; Weiss M; Brauns-Schubert P; Massoumi R; Borner C; Groß O; Yabal M; Charvet C; Maurer U
    Cell Rep; 2023 Jan; 42(1):111961. PubMed ID: 36640323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
    Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
    Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPATA2: more than a missing link.
    Schlicher L; Brauns-Schubert P; Schubert F; Maurer U
    Cell Death Differ; 2017 Jul; 24(7):1142-1147. PubMed ID: 28282038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.
    Wei R; Xu LW; Liu J; Li Y; Zhang P; Shan B; Lu X; Qian L; Wu Z; Dong K; Zhu H; Pan L; Yuan J; Pan H
    Genes Dev; 2017 Jun; 31(11):1162-1176. PubMed ID: 28701375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPATA2: New insights into the assembly of the TNFR signaling complex.
    Schlicher L; Maurer U
    Cell Cycle; 2017 Jan; 16(1):11-12. PubMed ID: 27635695
    [No Abstract]   [Full Text] [Related]  

  • 10. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains.
    Elliott PR; Leske D; Wagstaff J; Schlicher L; Berridge G; Maslen S; Timmermann F; Ma B; Fischer R; Freund SMV; Komander D; Gyrd-Hansen M
    Cell Rep; 2021 Oct; 37(1):109777. PubMed ID: 34610306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP.
    Goto E; Tokunaga F
    Biochem Biophys Res Commun; 2017 Mar; 485(1):152-159. PubMed ID: 28189684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
    Sun SC
    Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
    Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling.
    Hrdinka M; Fiil BK; Zucca M; Leske D; Bagola K; Yabal M; Elliott PR; Damgaard RB; Komander D; Jost PJ; Gyrd-Hansen M
    Cell Rep; 2016 Mar; 14(12):2846-58. PubMed ID: 26997266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ubiquitin ligases HOIP and cIAP1 are recruited to the TNFR2 signaling complex and mediate TNFR2-induced canonical NF-κB signaling.
    Borghi A; Haegman M; Fischer R; Carpentier I; Bertrand MJM; Libert C; Afonina IS; Beyaert R
    Biochem Pharmacol; 2018 Jul; 153():292-298. PubMed ID: 29378181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.
    Zhao Y; Ma CA; Wu L; Iwai K; Ashwell JD; Oltz EM; Ballard DW; Jain A
    J Biol Chem; 2015 Sep; 290(36):22076-84. PubMed ID: 26224629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
    Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
    Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
    Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
    Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.